PORT ST. LUCIE — After waiting more than two months for access to an experimental treatment, Port St. Lucie resident Russell Reed has begun taking a drug he hopes will slow the progression of his stage 4 pancreatic cancer.
Reed, 64, was recently approved to receive daraxonrasib, an investigational drug designed to target certain KRAS mutations associated with pancreatic cancer after his previous treatment options were no longer effective.
The decision to pursue the medication came after his chemotherapy stopped working…